Purple Biotech’s Assets Are First In Class For Solid Tumor Treatment, Analyst Says
HC Wainwright initiated coverage on Purple Biotech (NASDAQ:PPBT) with a Buy rating and a price target of $7. The company is working…
Cano Health Stock Plummets As CVS Health Abandons Buyout
Cano Health Inc (NYSE: CANO) shares plunged after reports that CVS Health Corp (NYSE: CVS) has decided not to pursue an acquisition of Cano.
Analyst Sees A Leader In Solid Tumor Cell Therapy In This Stock
HC Wainwright initiated coverage of Lyell Immunopharma Inc (NASDAQ:LYEL) with a Buy rating and a price target of $12 per share. Lyell…
NeuBase Lays Off 60% Of Workforce, Reprioritizes Pipeline To Focus On Gene Editing Tech
NeuBase Therapeutics Inc (NASDAQ:NBSE) announced restructuring plans to focus on the advancement of its platform in gene editing. The company has…
Medtronic First To Secure FDA Nod For Pacing Heart’s Natural Conduction System
The FDA has approved Medtronic plc’s (NYSE:MDT) expanded labeling of a cardiac lead that taps into the heart’s natural electrical system,…
Moderna Inks Deal For Updated COVID Shots For Low Income Countries
Moderna Inc (NASDAQ:MRNA) and Gavi, the Vaccine Alliance, agreed to cancel the remaining pending orders under the current COVID-19 vaccine supply…
Daré Bioscience’s Intravaginal Ring Improves Vasomotor, Vaginal Symptoms Of Menopause
Daré Bioscience Inc (NASDAQ:DARE) announced topline efficacy results from its Phase 1/2 trial of DARE-HRT1. DARE-HRT1 is a novel, investigational intravaginal…
Sage Therapeutics/Biogen Highlight Additional Data From Depression Candidate
Sage Therapeutics Inc (NASDAQ:SAGE) and Biogen Inc (NASDAQ:BIIB) presented additional data from the Phase 3 SKYLARK Study of zuranolone in adult women with…
Abbott Says Recent Recall Of Some Bottles Of Infant Formula Will Not Hamper Supply
Abbott Laboratories (NYSE:ABT) is voluntarily recalling some ready-to-feed baby formula liquid products, including Similac-branded items, due to inadequate sealing of some…
iPhone Manufacturing In Focus As China Orders Lockdown At Key Hub
The Chinese city of Zhengzhou, which is the manufacturing hub of Apple Inc.’s (NASDAQ: AAPL) iPhones, has reportedly locked down one of its most-populated districts to control a virus flare-up.